Barclays
BCS | NYSE
$22.76
+$0.46 (+2.06%)
Nov 2, 2026, 12:01 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 50.83B | 57.02B | 49.77B | 33.3B | 25.12B | 25.08B |
Cost of Revenue | 21.69B | 27.96B | 23.91B | 9.75B | 3.17B | 7.96B |
Gross Profit | 29.14B | 29.05B | 25.86B | 23.55B | 21.95B | 17.12B |
Operating Income | 9.14B | 8.28B | 6.45B | 7.04B | 8.19B | 2.89B |
Interest Income | 36.19B | 39.14B | 34.5B | 19.21B | 11.24B | 11.24B |
Pretax Income | 9.14B | 8.24B | 6.46B | 7.04B | 8.19B | 2.88B |
Net Income | 7.17B | 6.44B | 5.17B | 5.95B | 7.01B | 2.24B |
Selling & General & Admin | 2.73B | 11.94B | 11.77B | 10.95B | 1.97B | 9.12B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 17.27B | 8.88B | 7.63B | 5.57B | 11.79B | 5.11B |
Operating Expenses | 20B | 20.81B | 19.4B | 16.52B | 13.76B | 14.23B |
Interest Expense | 21.69B | 25.93B | 22B | 8.56B | 3.17B | 3.55B |
Selling & Marketing Expenses | 618M | n/a | n/a | n/a | 399M | n/a |
Cost & Expenses | 41.69B | 48.78B | 43.32B | 26.26B | 16.93B | 22.2B |
Income Tax Expense | 1.93B | 1.79B | 1.21B | 1.04B | 1.14B | 568.91M |
Shares Outstanding (Basic) | 3.45B | 3.69B | 3.86B | 4.08B | 4.25B | 4.33B |
Shares Outstanding (Diluted) | 3.45B | 3.82B | 3.97B | 4.22B | 4.36B | 4.42B |
EPS (Basic) | 1.80 | 1.44 | 1.12 | 1.24 | 1.48 | 0.35 |
EPS (Diluted) | 1.80 | 1.40 | 1.08 | 1.20 | 1.44 | 0.34 |
EBITDA | 10.9B | 9.94B | 8.24B | 8.76B | 9.87B | 4.62B |
EBIT | 9.14B | 8.24B | 6.46B | 7.04B | 8.19B | 2.88B |
Depreciation & Amortization | 1.76B | 1.7B | 1.78B | 1.72B | 1.67B | 1.73B |
Add to Watchlist
Select watchlists to add or remove BCS